Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, unveiled the Aria Smart Autoinjector platform to unlock innovation, differentiation and sustainability in the digital drug-delivery device market. This latest advancement introduces a small and simple, smart injection device featuring a reusable electronic drive unit and single-use, disposable cassettes to elevate patient care while reducing environmental impact.
Kevin Deane, VP, Innovation, Phillips-Medisize, said: “With the Aria Smart Autoinjector, we are disrupting this sector with a game-changing platform that brings the right functionality to market in the right form factor at the right time. Our goal from the outset has been to develop an injector that patients love, combining the simplicity of current disposable devices with the superior performance, sustainability and connectivity possible through an electronic, reusable device.”
Phillips-Medisize developed the Aria Smart Autoinjector with the compact size and “look and feel” of existing disposable autoinjectors in mind. Straightforward operation is aided by sound and light signals that indicate dose progress and completion. Simple sleeve-triggered activation and needle safety features are also provided. It is easy to use and is completed self-injection without training. Moreover, no users lifted the device too early during the injection while unanimously confirming the importance of sustainability.
The autoinjector consists of a built-in Bluetooth and optional RFID connectivity to ensure seamless data sharing of time-stamped dosing logs with smartphones, tablets and mobile healthcare apps. The result improves patient engagement, supports improved medication adherence and disease management. Aria easily connects with Phillips-Medisize’s companion mobile app and other third-party mobile apps.
The autoinjector can accommodate both 1ml and 2.25ml syringes in a common cassette. The Aria Smart Autoinjector platform is available in a basic model with a simple user interface for standard injection sequences and an advanced model with a screen-based Graphical User Interface (GUI) to offer more user interaction for complex injections.
